4.7 Article

SARS-CoV-2 seroprevalence among the general population and healthcare workers in India, December 2020-January 2021

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Public, Environmental & Occupational Health

Adjusting Coronavirus Prevalence Estimates for Laboratory Test Kit Error

Christopher T. Sempos et al.

Summary: This article discusses the importance of testing representative populations to determine the prevalence of COVID-19 and proposes methods for adjusting prevalence estimates to correct for testing error. Such adjustments can improve the accuracy of prevalence estimates and help in making better policy decisions.

AMERICAN JOURNAL OF EPIDEMIOLOGY (2021)

Article Medical Laboratory Technology

Evaluation of four commercial, fully automated SARS-CoV-2 antibody tests suggests a revision of the Siemens SARS-CoV-2 IgG assay

Christian Irsara et al.

Summary: This study evaluated the performance characteristics of four automated antibody assays for SARS-CoV-2, all of which showed very high diagnostic specificity. However, the sensitivities of some tests were slightly lower than manufacturer claims in samples collected at least 14 days after disease onset. The Siemens COV2G assay had distinctly lower sensitivity, necessitating a switch to the company's newly filed SARS-CoV-2 IgG assay for follow-up studies. Combination of multiple tests could be considered in clinical practice.

CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2021)

Article Immunology

SARS-CoV-2 Seroprevalence Survey Estimates Are Affected by Anti-Nucleocapsid Antibody Decline

Shelly Bolotin et al.

Summary: The study revealed that as time passed, the concentration of antibodies in SARS-CoV-2 positive specimens decreased, while the concentration in negative specimens increased. The association between the two tests also decreased over time, indicating a decline in anti-nucleocapsid antibodies.

JOURNAL OF INFECTIOUS DISEASES (2021)

Letter Medicine, General & Internal

Prevalence of SARS-CoV-2 in Karnataka, India

Manoj Mohanan et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2021)

Review Public, Environmental & Occupational Health

Review Seroprevalence of SARS-CoV-2 antibodies and associated factors in healthcare workers: a systematic review and meta-analysis

P. Galanis et al.

Summary: The seroprevalence of SARS-CoV-2 antibodies among HCWs is relatively high and influenced by factors such as gender, race, work environment, and protective measures.

JOURNAL OF HOSPITAL INFECTION (2021)

Article Public, Environmental & Occupational Health

SARS-CoV-2 antibody seroprevalence in India, August-September, 2020: findings from the second nationwide household serosurvey

Manoj Murhekar et al.

Summary: The seroprevalence of SARS-CoV-2 infection in individuals aged 10 years or older in India was 6.6%, with a higher prevalence of 7.1% in adults, and the highest prevalence seen in urban slum areas.

LANCET GLOBAL HEALTH (2021)

Review Public, Environmental & Occupational Health

Serological evidence of human infection with SARS-CoV-2: a systematic review and meta-analysis

Xinhua Chen et al.

Summary: This study synthesized and evaluated a large amount of global data on SARS-CoV-2 serological surveys, revealing variations in seroprevalence among different populations and in the infection-to-case ratio across regions. Most settings have not achieved herd immunity, and insights into the true proportion of infected population can be derived from serological detection data in routine confirmation.

LANCET GLOBAL HEALTH (2021)

Letter Public, Environmental & Occupational Health

Seroprevalence of SARS-CoV-2 in slums versus non-slums in Mumbai, India

Anup Malani et al.

LANCET GLOBAL HEALTH (2021)

Article Health Care Sciences & Services

Risk assessment and seroprevalence of SARS-CoV-2 infection in healthcare workers of COVID-19 and non-COVID-19 hospitals in Southern Switzerland

Luca Piccoli et al.

Summary: The study found that up to 10% of HCWs in acute care hospitals in Southern Switzerland have detectable SARS-CoV-2 antibodies. HCWs with exposure to COVID-19 patients have only a slightly higher absolute risk of seropositivity compared to those without, suggesting that the use of PPE and other measures aiming at reducing nosocomial viral transmission are effective. Households contact with known COVID-19 cases represents the highest risk of seropositivity.

LANCET REGIONAL HEALTH-EUROPE (2021)

Article Allergy

SARS-CoV-2 antibody testing-questions to be asked

Mustafa K. Oezcueruemez et al.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2020)

Article Biochemistry & Molecular Biology

Antibody responses to SARS-CoV-2 in patients with COVID-19

Quan-Xin Long et al.

NATURE MEDICINE (2020)

Article Multidisciplinary Sciences

Performance of nucleocapsid and spike-based SARS-CoV-2 serologic assays

Zahra Rikhtegaran Tehrani et al.

PLOS ONE (2020)

Article Immunology

Accurate serology for SARS-CoV-2 and common human coronaviruses using a multiplex approach

Sophie van Tol et al.

EMERGING MICROBES & INFECTIONS (2020)

Article Immunology

Prevalence of SARS-CoV-2 infection in India: Findings from the national serosurvey, May-June 2020

Manoj V. Murhekar et al.

INDIAN JOURNAL OF MEDICAL RESEARCH (2020)